Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)

Boehringer Ingelheim3,234 enrolled

Overview

The purpose is to explore the frequency of impulse control disorders in Parkinson's patients treated with different Parkinson's medications.

Study Type

OBSERVATIONAL

Enrollment

3,234

Conditions

Parkinson Disease

Eligibility

Sex: ALLMin age: 30 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: Observation Criteria: Male or female outpatients, aged 30 to 75 years of age, with idiopathic PD. Patients must be selected on the basis of a prospective recruitment plan documented at the site, with the objective of obtaining an unbiased representative sample. Patients must have been treated with anti-parkinson medication for a period of one year or greater and demonstrated a treatment response, in the opinion of the Investigator. Patients must be willing and able to comply with study procedures. Patients must be willing and able to give meaningful, written informed consent. This must be completed prior to beginning any study procedures, in accordance with GCP and local legislation. Exclusion Criteria:

Locations (49)

Outcomes

Primary Outcomes

Occurrence of current ImpulseControl Disorder(ICD) assessed via + res. of Modif.Massachusetts Gambling Screen,Modif.Minnesota Impulsive Disorder Interview for Sexuality,Modif.MIDI for Compulsive Buying,DSM-IV binge-eating research criteria questionnaire

Time frame: 6 months

Secondary Outcomes

The occurrence of a past (since onset of PD) ICD

Time frame: 6 months

Demographic and medical history measures

Time frame: up to 14 days after Visit 1

Scores on psychiatric/neuropsychological instruments/tests

Time frame: up to 14 days after Visit 1

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

248.619.01034 Neurological Physicians of Arizona

Gilbert, Arizona, United States

248.619.01007 Mayo Clinic - Scottsdale

Scottsdale, Arizona, United States

248.619.01025 Sun Health Research Institute

Sun City, Arizona, United States

248.619.01018 Margolin Brain Institute

Fresno, California, United States

248.619.01031 Pacific Neuroscience Medical Group, Inc.

Oxnard, California, United States

248.619.01016 San Francisco VA PD Research, Education, & Clinical Center

San Francisco, California, United States

248.619.01023 The Parkinson's Institute

Sunnyvale, California, United States

248.619.01021 Boehringer Ingelheim Investigational Site

Englewood, Colorado, United States

248.619.01027 Associated Neurologists, P.C.

Danbury, Connecticut, United States

248.619.01013 Molecular NeuroImaging

New Haven, Connecticut, United States

...and 39 more locations